Progressive age-related impairment of cognitive behavior in APP23 transgenic mice

Neurobiology of Aging

Volumn 24, Issue 2, 2003, Pages 365-378

  Kelly, Peter H ^a   Bondolfi, L ^b   Hunziker, D ^a   Schlecht, H P ^a   Carver, K ^a   Maguire, E ^a   Abramowski, D ^a   Wiederhold, K H ^a   Sturchler Pierrat, C ^a   Jucker, M ^b   Bergmann, R ^a   Staufenbiel, M ^a   Sommer, B ^a,c  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Amyloid; Alzheimer's disease; APP23 transgenic mice; Memory

Indexed keywords

AGING; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; GENE MUTATION; HABITUATION; MAZE TEST; MOUSE; NEOPHOBIA; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SPECIES COMPARISON; TASK PERFORMANCE; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; COGNITION; FEMALE; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOCORTEX; SWIMMING;

EID: 0037334107     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00098-2     Document Type: Article

References (40)

1. Arendash G.W., King D.L., Gordon M.N., Morgan D., Hatcher J.M., Hope C.E.et al. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 891:2001;42-53.
2. Auer S., Reisberg B. The GDS/FAST staging system. Int. Psychogeriatr. 9(Suppl. 1):1997;167-171.
3. Beatty W.W. Gonadal hormones and sex differences in nonreproductive behaviors in rodents: organizational and activational influences. Horm. Behav. 12:1979;112-163.
4. Bornemann K.D., Wiederhold K.-H., Pauli C., Ermini F., Stalder M., Schnell L.et al. Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am. J. Pathol. 158:2001;63-73.
5. Calhoun M.E., Kurth D., Phinney A.L., Long J.M., Hengemihle J., Mouton P.R.et al. Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice. Neurobiol. Aging. 19:1998;599-606.
6. Calhoun M.E., Wiederhold K.-H., Abramowski D., Phinney A.L., Probst A., Sturchler-Pierrat C.et al. Neuron loss in APP transgenic mice. Nature. 395:1998;755-756.
7. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M.et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2:1999;271-276.
8. Chen G., Chen K.S., Knox J., Inglis J., Bernard A., Martin S.J.et al. A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease. Nature. 408:2000;975-979.
9. De Jonghe C., Cruts M., Rogaeva E.A., Tysoe C., Singleton A., Vanderstichele H.et al. Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion. Hum. Mol. Genet. 8:1999;1529-1540.
10. D'Hooge R., Nagels G., Westland C.E., Mucke L., De-Deyn P.P. Spatial learning deficit in mice expressing human 751-amino acid beta-amyloid precursor protein. Neuroreport. 7:1996;2807-2811.
11. Dodart J.C., Meziane H., Mathis C., Bales K.R., Paul S.M., Ungerer A. Behavioral disturbances in transgenic mice overexpressing the V717F β-amyloid precursor protein. Behav. Neurosci. 113:1999;1-9.
12. Dodart J.C., Bales K.R., Gannon K.S., Greene S.J., DeMattos R.B., Mathis C.et al. Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model. Nat. Neurosci. 5:2002;452-457.
13. Franklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. San Diego: Academic Press, 1997.
14. Frick K.M., Burlingame L.A., Arters J.A., Berger-Sweeney J. Reference memory, anxiety and estrous cyclicity in C57BL/6NIA mice are affected by age and sex. Neuroscience. 95:2000;293-307.
15. Haass C., De Strooper B. The presenilins and Alzheimer's disease - proteolysis holds the key. Science. 286:1999;916-919.
16. Holcomb L.A., Gordon M.N., Jantzen P., Hsiao K., Duff K., Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav. Genet. 29:1999;177-185.
17. Hsiao K.K., Borchelt D.R., Olson K., Johannsdottir R., Kitt C., Yunis W.et al. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron. 15:1995;1203-1218.
18. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S.et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
19. Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D.et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 408:2000;979-982.
20. Kelly P.H., Hunziker D., Schlecht H.-P., Carver K., Abramowski D., Sturchler-Pierrat C.et al. Progressive behavioural impairment in amyloid precursor protein transgenic mouse line APP23. Soc. Neurosci. Abstr. 25:1999;1291.
21. Kelly P.H., Malanowski J. Cholinergic effects on spatial exploration and its memory. Can. J. Physiol. Pharmacol. 71:1993;352-364.
22. SW transgenic mouse model for Alzheimer's disease. Behav. Brain Res. 103:1999;145-162.
23. Klafki H., Abramowski D., Swoboda R., Paganetti P.A., Staufenbiel M. The carboxyl termini of beta-amyloid peptides 1-40 and 1-42 are generated by distinct gamma-secretase activities. J. Biol. Chem. 271:1996;28655-28659.
24. Lamb B.A., Bardel K.A., Kulnane L.S., Anderson J.J., Holtz G., Wagner S.L.et al. Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice. Nat. Neurosci. 2:1999;695-697.
25. Moechars D., Dewachter I., Lorent K., Reversé D., Baekelandt V., Naidu A.et al. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274:1999;6483-6492.
26. Moran P.M., Higgins L.S., Cordell B., Moser P.C. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. Proc. Natl. Acad. Sci. USA. 92:1995;5341-5345.
27. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J.et al. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 408:2000;982-985.
28. Phinney A.L., Deller T., Stalder M., Calhoun M.E., Frotscher M., Sommer B.et al. Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J. Neurosci. 19:1999;8552-8559.
29. Price D.L., Sisodia S.S. Mutant genes in familial Alzheimer's disease and transgenic models. Ann. Rev. Neurosci. 21:1998;479-505.
30. Reisberg B., Ferris S.H., De Leon M.J., Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am. J. Psychiat. 139:1982;1136-1139.
31. Rohan de Silva H.A., Patel A.J. Presenilins and early-onset familial Alzheimer's disease. Neuroreport. 8(8):1997;i-xii.
32. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T.et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400:1999;173-177.
33. Stalder M., Phinney A., Probst A., Sommer B., Staufenbiel M., Jucker M. Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am. J. Pathol. 154:1999;1673-1684.
34. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.-H., Mistl C., Rothacher S.et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA. 94:1997;13287-13292.
35. Venable N., Kelly P.H. Effects of NMDA receptor antagonists on passive avoidance learning and retrieval in rats and mice. Psychopharmacology. 100:1990;215-221.
36. Venable N., Kelly P.H. Effects of NMDA antagonists on memory processes in a novel two-trial swimming test. Behav. Pharmacol. 2:1991;161-169.
37. Voikar V., Koks S., Vasar E., Rauvala H. Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol. Behav. 72:2001;271-281.
38. Williams C.L., Meck W.H. The organizational effects of gonadal steroids on sexually dimorphic spatial ability. Psychoneuroendocrinology. 16:1991;155-176.
39. Yamaguchi F., Richards S.J., Beyreuther K., Salbaum M., Carlson G.A., Dunnett S.B. Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory. Neuroreport. 2:1991;781-784.
40. Zamanillo D., Sprengel R., Hvalby O., Jensen V., Burnashev N., Rozov A.et al. Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science. 284:1999;1805-1811.